Mineralys Therapeutics Inc (MLYS) CEO Jon Congleton Sells 72,797 Shares

By Yahoo! Finance | Jun 15, 2024 at 02:59 AM EST

Mineralys Therapeutics Inc (NASDAQ:MLYS) is developing precision therapies for cardiovascular and kidney diseases. Recent insider transactions, including shares sold at $12.7 each, show a balanced activity pattern. Investors should assess valuation metrics and insider trends when considering investment decisions.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.